Patent · US Active

Lung injury repair compositions and methods

US10328114B2 · kind B2 · utility

0Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2015
Grant dateJun 25, 2019
Priority date
Expiry dateOct 28, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/1709
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a pharmaceutical composition comprising Protein Kinase C Zeta (PKC-ζ) inhibitor and therapeutic methods for preventing or treating a pathological condition or symptom or for inducing proliferation of lung progenitor cells in a mammal by administering the PKC-ζ inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.